Stock News

As United Therapeutics Del (UTHR) Share Price Declined, Armistice Capital Boosted Position by $7.35 Million; Unitedhealth Group Com (UNH) Holder Blue Fin Capital Lifted Holding

UnitedHealth Group Incorporated (NYSE:UNH) Logo

Blue Fin Capital Inc increased its stake in Unitedhealth Group Inc Com (UNH) by 38.45% based on its latest 2017Q4 regulatory filing with the SEC. Blue Fin Capital Inc bought 1,365 shares as the company’s stock declined 0.93% with the market. The institutional investor held 4,915 shares of the medical specialities company at the end of 2017Q4, valued at $1.08 million, up from 3,550 at the end of the previous reported quarter. Blue Fin Capital Inc who had been investing in Unitedhealth Group Inc Com for a number of months, seems to be bullish on the $230.62B market cap company. The stock increased 0.20% or $0.481 during the last trading session, reaching $239.981. About 339,839 shares traded. UnitedHealth Group Incorporated (NYSE:UNH) has risen 32.42% since May 16, 2017 and is uptrending. It has outperformed by 20.87% the S&P500.

Armistice Capital Llc increased its stake in United Therapeutics Corp Del (UTHR) by 33.33% based on its latest 2017Q4 regulatory filing with the SEC. Armistice Capital Llc bought 50,000 shares as the company’s stock declined 21.89% with the market. The institutional investor held 200,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $29.59 million, up from 150,000 at the end of the previous reported quarter. Armistice Capital Llc who had been investing in United Therapeutics Corp Del for a number of months, seems to be bullish on the $4.75 billion market cap company. The stock increased 1.84% or $1.97 during the last trading session, reaching $109.02. About 47,044 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 23.69% since May 16, 2017 and is downtrending. It has underperformed by 35.24% the S&P500.

Among 27 analysts covering UnitedHealth Group (NYSE:UNH), 27 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. UnitedHealth Group had 88 analyst reports since September 2, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, December 7. The stock of UnitedHealth Group Incorporated (NYSE:UNH) earned “Buy” rating by Jefferies on Wednesday, June 21. Morgan Stanley maintained the shares of UNH in report on Wednesday, April 18 with “Overweight” rating. The company was maintained on Thursday, July 13 by Cowen & Co. The rating was maintained by Mizuho with “Buy” on Tuesday, July 18. The stock has “Buy” rating by Piper Jaffray on Friday, August 25. Oppenheimer maintained UnitedHealth Group Incorporated (NYSE:UNH) on Friday, July 7 with “Buy” rating. Credit Suisse maintained the shares of UNH in report on Wednesday, January 17 with “Buy” rating. The firm earned “Buy” rating on Wednesday, July 19 by RBC Capital Markets. The company was maintained on Saturday, September 23 by RBC Capital Markets.

More notable recent UnitedHealth Group Incorporated (NYSE:UNH) news were published by: Streetinsider.com which released: “Appaloosa 13F Shows New Stake in Wells Fargo (WFC) and Lam Research (LRCX), Increase in Micron (MU) MGM …” on May 15, 2018, also Streetinsider.com with their article: “Lone Pine’s 13F Shows New Stake in Dollar Tree (DLTR), Square (SQ), T-Mobile (TMUS) (more…)” published on May 15, 2018, 247Wallst.com published: “UBS Makes Big Health Care Swap in Top Performing Q-GARP Portfolio” on May 14, 2018. More interesting news about UnitedHealth Group Incorporated (NYSE:UNH) were released by: Bizjournals.com and their article: “UnitedHealthcare forms group to reach Fayetteville area” published on May 08, 2018 as well as 247Wallst.com‘s news article titled: “Why UnitedHealth Is Boasting Healthy Earnings” with publication date: April 17, 2018.

Investors sentiment increased to 0.96 in 2017 Q4. Its up 0.05, from 0.91 in 2017Q3. It is positive, as 51 investors sold UNH shares while 538 reduced holdings. 138 funds opened positions while 426 raised stakes. 806.07 million shares or 0.60% less from 810.94 million shares in 2017Q3 were reported. Clark Cap Mngmt Group invested 1.87% in UnitedHealth Group Incorporated (NYSE:UNH). Highlander Mgmt Ltd Company owns 500 shares or 0.08% of their US portfolio. New York-based Tiedemann Wealth Mgmt Ltd Llc has invested 0.02% in UnitedHealth Group Incorporated (NYSE:UNH). 500 are held by Ckw Financial Gru. Boston Common Asset Limited Liability Company owns 28,038 shares for 0.73% of their portfolio. Dodge And Cox, a California-based fund reported 9.42M shares. Main Street Lc has 2.88% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 85,695 shares. Peregrine Asset Advisers holds 1,531 shares or 0.17% of its portfolio. 3,925 were reported by Integral Derivatives Ltd Liability Corporation. Williams Jones And reported 18,357 shares or 0.09% of all its holdings. Seizert Cap Prns Llc holds 15,506 shares. Fulton Breakefield Broenniman Limited Liability Co invested 2.51% in UnitedHealth Group Incorporated (NYSE:UNH). Gulf Interest Bancorporation (Uk) holds 305,207 shares or 0.85% of its portfolio. Sheets Smith Wealth Mgmt reported 7,354 shares. Nordea Inv Mgmt reported 1.51M shares.

Blue Fin Capital Inc, which manages about $165.51M and $171.65 million US Long portfolio, decreased its stake in British Amern Tob Plc Sponsored Adr (NYSEMKT:BTI) by 9,105 shares to 10,383 shares, valued at $696,000 in 2017Q4, according to the filing.

Since December 14, 2017, it had 0 buys, and 12 sales for $32.64 million activity. RENFRO LARRY C also sold $5.08 million worth of UnitedHealth Group Incorporated (NYSE:UNH) shares. BURKE RICHARD T also sold $3.51 million worth of UnitedHealth Group Incorporated (NYSE:UNH) shares. Shares for $3.28 million were sold by Nelson Steven H. Shine Kenneth Irwin sold $48,025 worth of UnitedHealth Group Incorporated (NYSE:UNH) on Friday, January 19. Another trade for 10,000 shares valued at $2.38 million was made by HOOPER MICHELE J on Wednesday, January 31. On Thursday, January 18 the insider WILENSKY GAIL R sold $1.40 million.

Armistice Capital Llc, which manages about $1.00 billion US Long portfolio, decreased its stake in Madrigal Pharmaceuticals Inc by 152,000 shares to 60,000 shares, valued at $5.51M in 2017Q4, according to the filing. It also reduced its holding in Enanta Pharmaceuticals Inc (NASDAQ:ENTA) by 20,000 shares in the quarter, leaving it with 88,000 shares, and cut its stake in Tailored Brands Inc.

Investors sentiment increased to 1.14 in Q4 2017. Its up 0.15, from 0.99 in 2017Q3. It improved, as 26 investors sold UTHR shares while 112 reduced holdings. 53 funds opened positions while 105 raised stakes. 40.90 million shares or 1.42% less from 41.49 million shares in 2017Q3 were reported. Ahl Prns Limited Liability Partnership has 0.05% invested in United Therapeutics Corporation (NASDAQ:UTHR). Cornerstone Capital Mngmt Lc invested in 137,508 shares or 0.14% of the stock. Krensavage Asset Management Ltd Liability Corporation stated it has 294,429 shares or 13.58% of all its holdings. Guggenheim Capital Ltd Liability Corp has 0.04% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 103,231 shares. Great West Life Assurance Can has invested 0.04% in United Therapeutics Corporation (NASDAQ:UTHR). Hall Laurie J Trustee has invested 0.01% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Price T Rowe Assocs Md holds 0% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 132,850 shares. 10,571 are owned by Aurora Invest Counsel. Moreover, California Public Employees Retirement Sys has 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR). Ftb Advisors Inc reported 222 shares stake. Blackrock reported 4.77 million shares. 9,331 were accumulated by Thrivent For Lutherans. Moreover, Massachusetts Fincl Services Ma has 0% invested in United Therapeutics Corporation (NASDAQ:UTHR). Ellington Management Grp Limited Company owns 6,800 shares for 0.16% of their portfolio. New York State Common Retirement Fund stated it has 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR).

Among 12 analysts covering United Therapeutics (NASDAQ:UTHR), 2 have Buy rating, 3 Sell and 7 Hold. Therefore 17% are positive. United Therapeutics had 35 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Wednesday, December 27 by Wedbush. The firm earned “Equal-Weight” rating on Friday, February 26 by Barclays Capital. H.C. Wainwright downgraded it to “Neutral” rating and $95 target in Wednesday, June 15 report. Barclays Capital maintained United Therapeutics Corporation (NASDAQ:UTHR) on Thursday, May 3 with “Underweight” rating. Ladenburg Thalmann downgraded United Therapeutics Corporation (NASDAQ:UTHR) on Friday, April 29 to “Neutral” rating. The stock of United Therapeutics Corporation (NASDAQ:UTHR) has “Buy” rating given on Friday, July 31 by Argus Research. The company was maintained on Monday, November 13 by Wedbush. The rating was upgraded by Ladenburg Thalmann to “Buy” on Friday, October 28. The rating was maintained by Wedbush with “Buy” on Thursday, January 4. The stock of United Therapeutics Corporation (NASDAQ:UTHR) has “Hold” rating given on Thursday, October 26 by Cowen & Co.

More notable recent United Therapeutics Corporation (NASDAQ:UTHR) news were published by: Globenewswire.com which released: “Report: Exploring Fundamental Drivers Behind Reliance Steel & Aluminum, Goldman Sachs BDC, IBERIABANK …” on May 04, 2018, also Prnewswire.com with their article: “Stock Review for Drug Makers Investors — Endo, Ionis Pharma, Novo Nordisk, and United Therapeutics” published on April 30, 2018, Bizjournals.com published: “Analysts: Generic drugs won’t affect United Therapeutics ‘that much'” on May 09, 2018. More interesting news about United Therapeutics Corporation (NASDAQ:UTHR) were released by: Bizjournals.com and their article: “Taking out potential competition, drug maker says it will buy East Bay rival” published on April 30, 2018 as well as Nasdaq.com‘s news article titled: “Mid-Morning Market Update: Markets Open Higher; Sprint And T-Mobile To Merge In $26 Billion Deal” with publication date: April 30, 2018.

UnitedHealth Group Incorporated (NYSE:UNH) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *